1. Pink Sheet
  2. >>Market Access
  3. >>Pricing Debate

Supply Chain Truce In COVID-19: Will It Carry Over When Rx Price Debate Resumes?

 
• By Michael McCaughan

Manufacturers, insurers, pharmacies and PBMs are united in trying to assure ongoing access to medicines amid the COVID-19 outbreak. Will making common cause in a national emergency mean a more cooperative approach to addressing US drug pricing concerns when normalcy returns?

White Flag
Time To Put Down Their Weapons

There is nothing like a common enemy to bring feuding parties back together. 

The outbreak of COVID-19 appears to be having that effect on the key stakeholders in the prescription drug supply chain

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Pricing Debate

More from Market Access